Ivacaftor依伐卡托水合物,1134822-07-3

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ivacaftor hydrate

CAS No. : 1134822-07-3

MCE 国际站：Ivacaftor hydrate

产品活性：Ivacaftor hydrate (VX-770 hydrate) 是一种可口服的 CFTR 增强剂，可用于囊性纤维化的研究。

研究领域：Membrane Transporter/Ion Channel  |  Autophagy

作用靶点：CFTR  |  Autophagy

In Vitro: Ivacaftor (10 µM) increases the PC secretion activity by 3-fold for ABCB4-G535D, 13.7-fold for ABCB4-G536R, 6.7-fold for ABCB4-S1076C, 9.4-fold for ABCB4-S1176L, and 5.7-fold for ABCB4-G1178S. Ivacaftor corrects the functional defect of ABCB4 mutants. Ivacaftor (10 μM) significantly increases CFTR activity in W1282X-expressing cells compared to R1162X CFTR cells. Ivacaftor shows no significant activity against 160 targets tested including the GABA_A benzodiazepine receptor. Ivacaftor increases the chloride secretion with an EC₅₀ of 0.236 ± 0.200 μM, a 10-fold shift in potency compared to the F508del HBEs. In recombinant cells, VX-770 increases CFTR channel open probability (Po) in both the F508del processing mutation and the G551D gating mutation. VX-770 increases forskolin-stimulated I_T in temperature-corrected F508del-FRT cells by appr 6-fold with an EC₅₀ of 25 nM.

In Vivo: Ivacaftor (1-200 mg/kg, p.o.) exhibits good oral bioavailability in rat.

相关产品：Ivacaftor  |  Lumacaftor  |  Glibenclamide  |  CFTR(inh)-172  |  Tezacaftor  |  Ataluren  |  Elexacaftor  |  GlyH-101  |  (R)-BPO-27  |  Nesolicaftor  |  IOWH-032  |  Posenacaftor sodium  |  SRI-41315  |  GLPG1837  |  Navocaftor  |  PPQ-102  |  Cavosonstat  |  Galicaftor  |  Bamocaftor  |  5,​7,​4'-​Trimethoxyflavone  |  Icenticaftor  |  KM11060  |  GLPG2451  |  Olacaftor  |  SRI-37240  |  Chromanol 293B  |  NJH-2-057  |  CFTR corrector 2  |  Crinecerfont hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds